BiondVax Pharmaceuticals Overview

  • Founded
  • 2003
Founded
  • Status
  • Private
  • Employees
  • 25
Employees
  • Latest Deal Type
  • PIPE
  • Latest Deal Amount
  • $16.7M
Latest Deal Amount
  • Investors
  • 3

BiondVax Pharmaceuticals General Information

Description

BiondVax Pharmaceuticals Ltd is engaged in the healthcare sector. Its main activity is the commercialization and manufacturing of flu vaccine. Its product is designed to provide multi-season and multi-strain protection against some human influenza virus strains, including both seasonal and pandemic flu strains. The company recently concluded two Phase I/II trials in which the multimeric-001 universal flu vaccine was shown to be safe and immunogenic.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly Angel backed
Primary Industry
Pharmaceuticals
Other Industries
Other Healthcare Services
Primary Office
  • Jerusalem BioPark Building, 2nd Floor
  • Hadassah Ein Kerem Campus
  • Jerusalem 7403618
  • Israel
+972 00-000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BiondVax Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. PIPE 17-Jul-2019 $16.7M 0000 000.00 Completed Generating Revenue
7. 2PO 15-Sep-2017 000 000.00 000.00 Completed Generating Revenue
6. PIPE 02-Jan-2017 00.000 000.00 000.00 Completed Generating Revenue
5. 2PO 13-May-2015 00.00 000.00 000.00 Completed Generating Revenue
4. PIPE 01-Nov-2010 00.000 00.000 Completed Generating Revenue
3. IPO 18-Jun-2007 00000 00000 Completed Generating Revenue
2. Grant 23-Dec-2005 $1.1M Completed Generating Revenue
1. Angel (individual) Completed Generating Revenue
To view BiondVax Pharmaceuticals’s complete valuation and funding history, request access »

BiondVax Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
BiondVax Pharmaceuticals Ltd is engaged in the healthcare sector. Its main activity is the commercialization and manufac
Pharmaceuticals
Jerusalem, Israel
25 As of 2019
0000
00.00 0000-00-00
000000000 0000

000 0000

ion ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit
0000 000000000
Cambridge, MA
000 As of 0000
000.00
00000000 000.00

00000000

itation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehende
0000000000000
Cambridge, MA
0000 As of 0000
00000
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BiondVax Pharmaceuticals Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
VBI Vaccines(Rehovot) Corporate Backed or Acquired Cambridge, MA 000 000.00 00000000 000.00
00000000 000 Formerly VC-backed Cambridge, MA 0000 00000 00000000 00000
0000000 Formerly VC-backed Summit, NJ 0000 000.00 000000&0 000.00
To view BiondVax Pharmaceuticals’s complete competitors history, request access »

BiondVax Pharmaceuticals Executive Team (7)

Name Title Board Seat Contact Info
Ron Babecoff Chief Executive Officer & Founder
Elad Mark Chief Operating Officer, Operations
Shimon Hassin Ph.D Chief Administrative Officer
Tamar Ben-Yedidia Ph.D Chief Scientific Officer
Ester Abramov Executive
You’re viewing 5 of 7 executive team members. Get the full list »

BiondVax Pharmaceuticals Board Members (8)

Name Representing Role Since
Avner Rotman Ph.D BiondVax Pharmaceuticals Board Member 000 0000
Mark Germain Self Chairman & Board Member 000 0000
Morris Laster MD Self Board Member 000 0000
Ruth Yakar Ph.D Self Board Member 000 0000
Samuel Moed BiondVax Pharmaceuticals Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

BiondVax Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BiondVax Pharmaceuticals Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
aMoon Fund Venture Capital Minority 000 0000 000000 0
Angels High Tech Investments Corporation Minority 000 0000 000000 0
Yorkville Advisors Hedge Fund Minority 000 0000 000000 0
To view BiondVax Pharmaceuticals’s complete investors history, request access »